Actively Recruiting
Implementation of Tailored Interventions to Treat Harmful Alcohol and Drug Use for Medical Patients in Norwegian Hospitals and the Municipality Service - AlcoTail
Led by Oslo University Hospital · Updated on 2025-07-31
4200
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
Sponsors
O
Oslo University Hospital
Lead Sponsor
S
St. Olavs Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are investigating how a new intervention for harmful use of alcohol and psychoactive medicinal drugs can be implemented and its effects among hospital inpatients. This study responds to health concerns related to alcohol consumption and non-prescribed or combined use of psychoactive drugs. It includes two groups of 2500 patients each: one before and one after introducing the intervention, aiming to evaluate its impact on consumption, motivation to reduce use, and mental distress. Patients admitted before the intervention receive usual acute medical care and form the control group. After implementation, patients in the case group are routinely screened for harmful alcohol use using the AUDIT-C tool, with varying advice or treatment based on their scores. Those at risk of severe withdrawal receive specialized care. Psychoactive drug use is also assessed pharmacologically, with adjustments or referrals as needed. Blood samples are collected for biomarker analysis at baseline and, for the case group, again after 2 months. Participants provide baseline data through questionnaires on alcohol and drug use and mental health, alongside blood sample analysis. After 12 months, these data are linked with patient records and national registries to assess changes in consumption, health outcomes, healthcare use, and referrals. All data are anonymized and securely stored. The study involves ongoing monitoring and statistical analysis to compare outcomes between groups over time.
CONDITIONS
Brief Title
AlcoTail - Implementation of Tailored Interventions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients admitted to Medical wards
You will not qualify if you...
- Inability to understand written and verbal Norwegian
- Cognitive or mental inability to consent to participation
- Injury or planned surgery as primary reason for admission
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At inclusion and up to 12 months follow-up
Participants who undergo routine acute medical care are observed, with baseline data collected including questionnaires and blood samples for alcohol and drug biomarkers.
1 baseline visit; data collection continues through medical records and registries up to 12 months
Duration - Up to 2 months with possible blood sample at 2 months after inclusion
Participants identified with harmful alcohol use or non-prescribed psychoactive medicinal drug use through routine hospital screening receive tailored advice, blood sample analysis, pharmacological assessments, and if necessary, referrals to specialized addiction treatment.
1 baseline visit and 1 follow-up blood sample visit at 2 months (case group only)
Duration - 12 months
Participants' health outcomes, healthcare service use, and specialist referrals are monitored using patient journal data and various registries for up to 12 months after inclusion.
No in-person visits; data collected via medical records and registries
Trial Site Locations
Total: 1 location
1
Oslo University Hospital
Oslo, Norway
Actively Recruiting
Research Team
A
Anners Lerdal, PhD
S
Stig Tore Bogstrand, PhD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here